Nonetheless, the findings suggest that improving BMPR2 signaling in addition to the beneficial sequelae of inhibiting NE, described earlier in this review, could reverse the vascular remodeling observed in PAH. Here, BMPR2 is linked to pulmonary arterial hypertension.